(Source: Evotec AG) * STRENGTHENS CELL-BASED SCREENING AND REAGENT PLATFORM AT EVOTEC'S HAMBURG SITE * ADDS HIGH-MARGIN BUSINESS WITH AN EXPECTED REVENUE OF MORE THAN EUR1.0 M IN 2013 * INITIAL PURCHASE PRICE OF APPROX EUR1.2 M IN CASH PLUS AN EARN-OUT PAYMENT DEPENDENT ON BUSINESS PERFORMANCE Hamburg, Germany - 03 January 2013: Evotec AG (Frankfurt Stock Exchange: EVT, TecDAX) today announced the acquisition of all shares in Cell Culture Service GmbH (CCS), a Hamburg-based company which supports the cell culture needs of a world-wide customer base of biotech and Pharmaceutical companies. CCS is one of the leading suppliers of custom cells and cell-based reagents such as recombinant...
0 Responses to Evotec acquires Cell Culture Service GmbH (Evotec AG)